ACF Cannulas in the ED: Many Insertions, Few Need Contrast

Study Overview
A retrospective cohort study in a metropolitan Australian ED examined whether antecubital fossa (ACF) peripheral IV cannulas (PIVCs) are actually needed for contrast-enhanced CT. Among 447 eligible patients, researchers measured how often ACF PIVCs led to contrast use and which patient or clinical factors predicted contrast administration.

Key Findings

• Big mismatch: 80% of PIVCs were placed in the ACF, yet only 27% of patients received contrast CT—meaning ~73% of ACF insertions were potentially avoidable.
• Predictors: Higher odds of contrast use with gastrointestinal or neurological presentations; lower odds among female patients.
• Guideline-practice gap: ACF placement—linked to higher infection and failure risk—was frequently chosen “just in case,” rather than for a confirmed imaging plan.
• Patient impact: Unnecessary ACF cannulas add pain, failure risk, and downstream costs without clear benefit.

Implications

• Don’t default to ACF: Prefer forearm/hand sites unless contrast CT is very likely.
• Decide with data: Use triage prompts or order sets that pair cannulation site with an imaging plan; partner with radiology to define when ACF is warranted.
• Audit and feedback: Track ACF insertions versus actual contrast use; share results with clinicians.
• Support alternatives: Encourage ultrasound-guided peripheral access or early escalation pathways when needed, rather than routine ACF placement.
• Keep patients central: Choose site based on comfort, dwell time needs, and complication risk—not habit.

Read more:https://onlinelibrary.wiley.com/doi/10.1111/1742-6723.70208 

Authors: Hui (Grace) Xu; Anna Doubrovsky; Nicola Robinson; Claire Rickard; Gillian Ray-Barruel.